AAAP will be closed for the HolidaysWe will be closed starting December 22, 2023 and returning January 2, 2024. If you have an emergency, please contact 401-524-0909. Otherwise use our contact us form to send us a message. Happy Holidays and Peace to all in the New Year!
AAAP will be closed for the HolidaysWe will be closed starting December 22, 2023 and returning January 2, 2024. If you have an emergency, please contact 401-524-0909. Otherwise use our contact us form to send us a message. Happy Holidays and Peace to all in the New Year!
This April, as we observe Alcohol Awareness Month, don’t miss the opportunity to check out and share the following resources at the Evidence-Based Practices Resource Center (EBPRC)…
A new study by health economists at nonprofit research institute RTI International adds to recent research demonstrating a lack of access to affordable mental health and substance use disorder treatment in the U.S.
DEA supports collaboration amongst all DEA registrants to ensure there is an adequate and uninterrupted supply of MOUD products when appropriately prescribed. Distributors should carefully examine any quantitative thresholds they have established to ensure that individuals with opioid use disorder (OUD) who need buprenorphine are able to access it without undue delay.
Today, the U.S. Department of Health and Human Services (HHS) marked two years of its Overdose Prevention Strategy (Strategy) by announcing bold new actions to combat overdoses.
The American Academy of Addiction Psychiatry (AAAP) and the American Society of Addiction Medicine (ASAM) have jointly developed a crucial Clinical Practice Guideline on the Management of Stimulant Use Disorder (StUD). This groundbreaking guideline is designed to provide evidence-based strategies and clinically informed standards of care for the prevention and treatment of StUD, stimulant intoxication, and stimulant withdrawal.
As Congressionally-mandated, medical practitioners have a new role to help patients fighting to sustain recovery and prevent opioid overdoses. All medical registrants submitting a new or renewing a current registration must attest to completing an eight-hour training to treat patients overcoming opioid and other substance use disorders.
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.